Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

FDA Drug Application 020749 by GLAXOSMITHKLINE CONS

Application Number020749
Application Type New Drug Application
Sponsor ApplicantGLAXOSMITHKLINE CONS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP010/17/1997N6420000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020749_lamisil_toc.cfm 8/7/2003
AP05/13/1999SCM       
AP03/27/2003SLR4657004   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20749slr004_lamisil_lbl.pdf 3/28/2003
AP03/27/2003SLR5284004   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20749slr004ltr.pdf 4/15/2003
AP04/30/2001SCS       
AP012/27/2001SCM       
AP01/22/2002SCM       
AP08/2/2002SCP       




Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS